FDA approves meningococcal vaccine for infants

The FDA has approved the use of the meningococcal vaccine for infants. Menactra was approved to prevent N. meningitidis for use in infants. The approval is for a 2 dose series to be administered 3 months apart. It is not yet officially included in the immunization schedule but we are definitely looking forward to its inclusion.